Loading data
AMENYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 7.4 bn USD | 6.94 bn USD | 6.6 bn USD | 6.15 bn USD | — |
| Cost of revenue | 4.73 bn USD | 4.46 bn USD | 4.21 bn USD | 4.01 bn USD | 3.63 bn USD |
| Research and development expense | 236.1 m USD | 236.6 m USD | 220.8 m USD | 198.8 m USD | 194.2 m USD |
| Selling, general and administrative expense | 757.12 m USD | 696.91 m USD | 677.01 m USD | 644.58 m USD | 603.94 m USD |
| Operating profit | 1.91 bn USD | 1.78 bn USD | 1.71 bn USD | 1.5 bn USD | 1.31 bn USD |
| Interest expense | — | — | 81.8 m USD | 83.19 m USD | 80.38 m USD |
| Profit before tax | 1.8 bn USD | 1.66 bn USD | 1.61 bn USD | 1.43 bn USD | 1.22 bn USD |
| Income tax expense | 318.2 m USD | 285.42 m USD | 293.22 m USD | 269.15 m USD | 233.12 m USD |
| Net income (reported basis) | 1.48 bn USD | 1.38 bn USD | 1.31 bn USD | 1.16 bn USD | 990.1 m USD |
| Basic earnings per share | 6.42 USD/share | 5.95 USD/share | 5.7 USD/share | 5.04 USD/share | 4.29 USD/share |
| Diluted earnings per share | 6.4 USD/share | 5.93 USD/share | 5.67 USD/share | 5.01 USD/share | 4.25 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.